OR WAIT null SECS
July 18, 2017
The addition of 20,000 sq. ft. of manufacturing and office space increases Avecia’s Milford, Ma, oligonucleotide capacity to 3.0 mol.
July 05, 2017
Cannabinoids have potential to treat a variety of diseases, but pharmaceutical companies must first develop cost-effective ways to access pharmaceutically pure materials without marijuana cultivation.
A Supreme Court decision and improvements in analytical processes may speed the biosimilar approval process.
July 02, 2017
Poly(lactide-glycolide) has been used for drug-delivery applications because of its beneficial physicochemical properties, long safety record, and reliable commercial supply.
Industrial-scale continuous API manufacturing may offer cost and safety benefits.
As pharma models changed during the past 40 years, contract manufacturing capacity and services evolved to meet demand.
June 28, 2017
BASF plans to build a new world-scale ibuprofen production plant in Ludwigshafen and expand ibuprofen capacities at its Bishop, Texas plant.
June 16, 2017
SK Biotek plans to operate the Swords, Ireland API manufacturing facility as a contract development and manufacturing site.
June 14, 2017
Sartorius Stedim Biotech combined the company’s ambr 15 bioreactor system with the Nova BioProfile FLEX2 cell culture analyzer for laboratory experiments.
June 08, 2017
Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing.